Long-lasting in vitro hematopoiesis derived from primate embryonic stem cells

Area of Science:

• Stem cell research
• Hematopoiesis
• Primate models

Background:

• Human embryonic stem cells (ESCs) can be differentiated into hematopoietic cells.
• Clinical applications require preclinical validation in relevant animal models, such as primates.

Purpose of the Study:

• To establish a robust and abundant method for inducing hematopoietic cells from primate ES cells.
• To facilitate preclinical studies for potential cell-based therapies.

Main Methods:

• Utilized a cynomolgus monkey ES cell line (CMK-6).
• Adapted feeder cell-based induction of hematopoiesis using OP9, C2C12, and C3H10T1/2 cell lines.
• Investigated the effects of vascular endothelial growth factor (VEGF) and insulin-like growth factor-II (IGF-II).

Main Results:

• VEGF and IGF-II demonstrated a strong synergistic effect on hematopoiesis induction.
• C3H10T1/2 feeder cells were highly effective, supporting blood cell production for up to 5 months.
• ES cell derivatives consistently produced mature, terminally differentiated blood cells over the extended period.

Conclusions:

• Developed an original method for abundant, long-term production of enriched blood cells from primate ES cells.
• The method provides a valuable in vitro model for studying primate hematopoiesis and related diseases.
• This approach may be crucial for preclinical transfusion therapy studies in primate models.